Pharmaceuticals Market Research Reports & Industry Analysis
Filter your search
Research Assistance
Pharmaceuticals Industry Research & Market Reports
-
Argentina Pharmaceuticals and Healthcare Report Q4 2017
...demand for chronic disease treatment. Moreover, ongoing improvementsto the regulatory environment pose upside risks to patented medicine sales. Headline Expenditure Projections Pharmaceuticals: ARS80.27bn (USD5.43bn) in 2016 to ARS97.10bn (USD5.88bn) in 2017; +21.0% inlocal currency terms ... Read More
-
Brazil Pharmaceuticals and Healthcare Report Q4 2017
...challenging market due to price and market access controls. Headline Expenditure Projections Pharmaceuticals: BRL73.65bn (USD19.87bn) in 2016 to BRL77.64bn (USD23.89bn) in 2017; +5.4%in local currency terms and +20.2% in US dollar terms. Local currency forecast ... Read More
-
Zambia Pharmaceuticals and Healthcare Report Q4 2017
...force unemployed, geographical and financial access to medicines forthe majority of the population is largely restricted. Headline Expenditure Forecast Pharmaceuticals: ZMW1.80bn (USD174mn) in 2016 to ZMW1.93bn (USD204mn) in 2017; +7.4% inlocal currency terms and 17.2% ... Read More
-
Singapore Pharmaceuticals and Healthcare Report Q4 2017
...involvement of the government,Singapore's pharmaceutical and healthcare sector is set to grow and evolve, making the country's healthcaresector increasingly attractive to investors, thereby boosting both the country's economy and the population'soverall well-being. Pricing will also ... Read More
-
China Contract Research Organization(CRO) Industry Report, 2017-2021
...the development of new drugs assisted by CRO firms in recent years, stimulating the progression of global CRO industry which had a market size of USD31.7 billion in 2016. There are more than 1,100 CRO ... Read More
-
Sub-Saharan Africa Pharmaceuticals and Healthcare Report Q4 2017
...the region, where the rewards are brighter forinnovative drugmakers' portfolios and have longer-term potential. Headline Expenditure Projections Pharmaceuticals: USD12.0bn in 2016 to USD12.3bn in 2017; 3.1% in US dollar terms. Healthcare: USD79.1bn in 2016 to ... Read More
-
Australia Pharmaceuticals and Healthcare Report Q4 2017
...create revenue challenges for multinationalpharmaceutical firms. While innovative pharmaceutical treatments will stand to gain from the introductionof a Priority Review and a Provisional Approval process in the country, the net benefit will remainconstrained by the ... Read More
-
El Salvador Pharmaceuticals and Healthcare Report Q4 2017
...of Health's efforts to solicit outside assistance to bolster healthcareprovision in all quarters of the country. Despite improvements in the regulatory environment since TheMedicines Law of El Salvador was approved in 2012, steady multinational FDI ... Read More
-
Latin America Pharmaceuticals and Healthcare Report Q4 2017
...regulatory advancements will maintaindrugmaker interest in the long term. Headline Expenditure Projections Pharmaceuticals: USD57.5bn in 2016 to USD63.3bn in 2017; 10.0% in US dollar terms. Healthcare: USD363.6bn in 2016 to USD404.8bn in 2017; 11.3% in ... Read More
-
Middle East And North Africa Pharmaceuticals and Healthcare Report Q4 2017
...diversifiedtherapeutic development from firms in the region. Crucially, a country-specific approach is integral forpharmaceutical companies as they must adapt to the evolving pricing landscape, differing levels of patentprotection and the level of competition within each ... Read More
-
Asia Pacific Intrauterine Contraceptive Device Market Forecast 2017-2025
...generating $1832 million over the forecast period of 2017-2025. MARKET INSIGHTS The market is segmented by type and by product. Presently, the copper IUCD market holds a major share of the market. The market is ... Read More
-
North America Intrauterine Contraceptive Device Market Forecast 2017-2025
...forecast period of 2017-2025 at a CAGR of 3.37%, generating $1156 million by the end of 2025. MARKET INSIGHTS The market is being presented with opportunities like a high rate of unintended pregnancies, teen pregnancies, ... Read More
-
Europe Intrauterine Contraceptive Device Market Forecast 2017-2025
...be attributed to the estimated rise in the market’s CAGR by 3.24% over the forecast period of 2017-2025. MARKET INSIGHTS According to the Guttmacher Institute, IUCD is an essential part of family planning in the ... Read More
-
Global Intrauterine Contraceptive Market Forecast 2017-2025
...projected to expand at a CAGR of 3.75%, increasing its revenue from $ 3534 million in 2016 to $4886 million by 2025 over the forecast period of 2017-2025. The key factors favoring the use of ... Read More
-
2018 U.S. Pharmaceutical Preparation Mfg.. Industry-Industry & Market Report
...the size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. Other data include financial ratios, number of firms, payroll, industry definition, 5-year historical trends on ... Read More
-
2018 U.S. Psychiatric & Substance Abuse Hospitals Industry-Industry & Market Report
...estimates on the size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. Other data include financial ratios, number of firms, payroll, industry definition, 5-year historical ... Read More
-
The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis
...forecast period to reach $12.9bn in 2021 driven by safety and efficacy improvements of the new generation biologics. The psoriasis treatment market is dominated by topical agents and photo therapy for the non-severe forms (mainly ... Read More
-
ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review
...you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Sothema (SOT) - Financial and Strategic SWOT Analysis Review
...a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ... Read More
-
Zambon Company SpA - Strategic SWOT Analysis Review
...key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ... Read More
-
China Chemical & Pharmaceutical Co Ltd (1701) - Financial and Strategic SWOT Analysis Review
...GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by ... Read More
-
Vectura Group Plc (VEC) - Financial and Strategic SWOT Analysis Review
...to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Women's Health Devices - Medical Devices Pipeline Assessment, 2017
...stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides ... Read More
-
Slovakia Pharmaceuticals and Healthcare Report Q4 2017
...this willpose fewer risks to drugmakers, Slovakia's market has less potential for growth than some of its similarlydevelopedregional neighbours, notably Poland. Headline Expenditure Projections Pharmaceuticals: EUR1.72bn (USD1.90bn) in 2016 to EUR1.80bn (USD1.98bn) in 2017; +4.7% ... Read More
-
Tunisia Pharmaceuticals and Healthcare Report Q4 2017
...a notable impact on developments within the pharmaceutical sector and wider economy;however, the actual benefits will take time to materialise. Crucially, higher growth opportunities willpresent themselves within the generic medicines sector, while the high industry-associated ... Read More
